Stock Market News

UBS bullish on AstraZeneca's baxdrostat, cautious on AVANZAR

Jun 12, 2025 - 09:24
 0
UBS bullish on AstraZeneca's baxdrostat, cautious on AVANZAR
Read More

Tags:

Previous Article

RBC sees Rentokil in “waiting room” but stays bullish on long-term outlook

Next Article

This AI already found EIGHT 12%+ winners in June - Here’s what it’s signalling now

Related Posts

Citi shuffles MedTech stocks: BDX downgraded, ITGR rais...

May 22, 2025  0

ADI, TXN named top semiconductor picks by Citi

Jun 6, 2025  0

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

Pfizer in deal with China's 3SBio to license cancer dru...

May 20, 2025  0